U-M Researcher Leads SU2C and Prostate Cancer ... - mCancer Talk

$10 million, three-year grant funds research to develop personalized treatments for advanced prostate cancer

Arul Chinnaiyan, M.D., Ph.D.

Stand Up To Cancer (SU2C) and the Prostate Cancer Foundation (PCF), along with the American Association for Cancer Research (AACR), SU2C?s scientific partner, announced the formation of a new Dream Team dedicated to prostate cancer research.

U-M researcher Arul Chinnaiyan, M.D., Ph.D., will be the principal investigator on this new $10 million ?Dream Team? grant from Stand Up to Cancer and the Prostate Cancer Foundation. ??Utilizing this Dream Team grant, we will be able to bring together great scientists and clinicians from around the world to join in the fight against metastatic prostate cancer. We hope this unique model of research will lead to patient benefit in the short term,? said Chinnaiyan.

The project involves researchers at seven centers and will focus on developing new personalized therapies for advanced prostate cancer. Watch the following video to hear about the scope of the project from those involved.

The researchers expect clinical trials to open in early 2013. The foundation of this project is based in Dr. Chinnaiyan?s groundbreaking discovery that two genes fuse together in about half of all prostate cancers. The researchers will use new sequencing technology that is already being employed in the Cancer Center to help target therapies based on the unique molecular makeup of each patient?s tumor.

Read more about the ?Dream Team? and those involved.

Follow the Dream Team and get updates on their progress.

devil inside ted nugent dash diet how to make moonshine joel osteen emmy rossum moonshine